Ibuprofen Abece

Ibuprofen, the active ingredient in Ibuprofen Abece, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It treats mild to moderate pain, fever, and inflammatory joint conditions in adults and children when appropriate. GNH USA supplies Ibuprofen Abece as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts as an analgesic and anti‑inflammatory agent across several common conditions.

Mild to moderate pain: provides relief from headaches, dental pain, musculoskeletal aches, and menstrual cramps. Fever: lowers elevated body temperature associated with infections or inflammatory states. Osteoarthritis: reduces joint pain and improves mobility in degenerative joint disease. Rheumatoid arthritis: helps control inflammation and pain during disease flares.

Adverse reactions may range from mild, transient symptoms to rare but serious events.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Severe gastrointestinal bleeding or ulceration. - Anaphylactic or severe allergic reactions. - Elevated liver enzymes or hepatitis. - Acute kidney injury or reduced renal function.

Before using Ibuprofen, consider the following safety measures. - Assess renal function: avoid in patients with severe renal impairment. - Monitor gastrointestinal risk: use with food or a proton‑pump inhibitor if ulcer history exists. - Avoid in known hypersensitivity to ibuprofen or other NSAIDs. - Use cautiously in cardiovascular disease: may increase thrombotic risk. - Pregnancy and lactation: consult a healthcare professional before use. - Store at room temperature: keep in the original pack, protect from moisture and heat.

Ibuprofen can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Selective COX‑2 inhibitors: additive renal toxicity. - Lithium: increased serum lithium concentrations. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible decline in renal function. - Diuretics: risk of volume depletion and renal impairment. - SSRIs or other serotonergic agents: increased bleeding tendency.